Economic Benefits of a Routine Second Dose of Combined Measles, Mumps and Rubella Vaccine in Canada
Author(s) -
Marc Rivière,
R. Tretiak,
Carey Levinton,
Catherine Fitzsimon,
Caroline Leclerc
Publication year - 1997
Publication title -
canadian journal of infectious diseases and medical microbiology
Language(s) - English
Resource type - Journals
eISSN - 1918-1493
pISSN - 1712-9532
DOI - 10.1155/1997/215175
Subject(s) - medicine , mmr vaccine , measles , rubella vaccine , rubella , vaccination , christian ministry , environmental health , immunization , pediatrics , measles mumps rubella vaccine , family medicine , immunology , political science , law , antigen
To evaluate the potential economic benefits of a program for a second routine dose of combined measles, mumps and rubella (MMR) vaccine, administered to children in Canada.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom